Camptocormia due to myotinilopathy, Parkinson’s disease, or both? : Camptocormia and axial myopathy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Camptocormia due to myotinilopathy, Parkinson’s disease, or both? ; volume:5 ; number:1 ; day:14 ; month:9 ; year:2023 ; pages:1-2 ; date:12.2023
Neurological research and practice ; 5, Heft 1 (14.9.2023), 1-2, 12.2023
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s42466-023-00276-2
- URN
-
urn:nbn:de:101:1-2024020613331081556684
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Finsterer, Josef
- SpringerLink (Online service)
Other Objects (12)
Reply to: Camptocormia due to myotinilopathy, Parkinson’s disease, or both?
Myofibrillar myopathy: a rare but important differential diagnosis of camptocormia in a patient with Parkinson’s Disease
Axial impairment and falls in Parkinson’s disease: 15 years of subthalamic deep brain stimulation
Parkinson
Parkinson
Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson’s disease
Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Reply to: Camptocormia due to myotinilopathy, Parkinson’s disease, or both?
Myofibrillar myopathy: a rare but important differential diagnosis of camptocormia in a patient with Parkinson’s Disease
Axial impairment and falls in Parkinson’s disease: 15 years of subthalamic deep brain stimulation
Parkinson
Parkinson
Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson’s disease
Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Reply to: Camptocormia due to myotinilopathy, Parkinson’s disease, or both?
Myofibrillar myopathy: a rare but important differential diagnosis of camptocormia in a patient with Parkinson’s Disease
Axial impairment and falls in Parkinson’s disease: 15 years of subthalamic deep brain stimulation
Parkinson
Parkinson
Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson’s disease
Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
Nutraceuticals in Parkinson’s Disease